- DocumentoWHO-WHE-SPP-2023.2-engenviado porMohamedRefaatMohamed
- DocumentoWHO-2019-nCoV-vaccines-SAGE_recommendation-inactivated-2023.1-engenviado porMohamedRefaatMohamed
- DocumentoWER9832-eng-freenviado porMohamedRefaatMohamed
- DocumentoRisk-based Guideline for Post-Marketing Quality Surveillance of 2020enviado porMohamedRefaatMohamed
- Documentoد. محمد راتب النابلسي Dr.mohamad Rateb Al-Nabulsi…enviado porMohamedRefaatMohamed
- Documento2017 Access to Vaccines Indexenviado porMohamedRefaatMohamed
- DocumentoWHO Guidelines Validation Qualification Systems-utilities-equipment-Appendix6 QAS16-673 290652016enviado porMohamedRefaatMohamed
- DocumentoTRS 978 61st Report Annex 6 PQ Vaccine Procedureenviado porMohamedRefaatMohamed
- DocumentoFDA Regulation of Pharmacenviado porMohamedRefaatMohamed
- DocumentoArthritis _ Rheumatism Volume 63 Issue 10 2011 [Doi 10.1002_art.30505] Robert a. Colbert; Bruce N. Cronstein -- Biosimilars- The Debate Continuesenviado porMohamedRefaatMohamed
- DocumentoTrends in Biotechnology Volume 27 Issue 7 2009 [Doi 10.1016_j.tibtech.2009.03.005] Leyre Zuñiga; Begoña Calvo -- Regulatory Aspects of Biosimilars in Europeenviado porMohamedRefaatMohamed
- DocumentoVy Des Champs Avenue Du Juraenviado porMohamedRefaatMohamed
- DocumentoPICS Blueprintenviado porMohamedRefaatMohamed
- DocumentoWHO_TRS_908_A6enviado porMohamedRefaatMohamed
- DocumentoWHO_V&B_99.10enviado porMohamedRefaatMohamed
- DocumentoFDA Checklistenviado porMohamedRefaatMohamed
- DocumentoWHO Effective Drug Regulationsenviado porMohamedRefaatMohamed
- DocumentoFull - Counterfeit Drugs and National Securityenviado porMohamedRefaatMohamed
- DocumentoWHO Anticounterfeiting - Englishenviado porMohamedRefaatMohamed
- DocumentoWHO Anticounterfeiting - Arabicenviado porMohamedRefaatMohamed
- DocumentoFAQ HEPAs and ULPAsenviado porMohamedRefaatMohamed
- DocumentoGUIDELINE ON THE CLINICAL DEVELOPMENT OF PRODUCTS FOR SPECIFIC IMMUNOTHERAPY FOR THE TREATMENT OF ALLERGIC DISEASESenviado porMohamedRefaatMohamed
- DocumentoGuia+de+validação+de+limpeza+para+Farmoquímicasenviado porMohamedRefaatMohamed
- DocumentoWHO Recommended Survillance Standardsenviado porMohamedRefaatMohamed
- DocumentoKids Biotech Basics Activity Bookenviado porMohamedRefaatMohamed
- Documentoمع المتنبى - طه حسينenviado porMohamedRefaatMohamed
- DocumentoWHO_TRS_1enviado porMohamedRefaatMohamed
- DocumentoWHO PQS Refrigerator or combined refrigerator water-pack freezerenviado porMohamedRefaatMohamed
- DocumentoWHO PQS Water-pack freezerenviado porMohamedRefaatMohamed
- DocumentoWHO PQS Dometic Coolantpackenviado porMohamedRefaatMohamed
- DocumentoWHO PQS Vaccine freezer or combined vaccine and water-pack freezerenviado porMohamedRefaatMohamed
- Documentopqs_e01_cr_fr01_vp2_2enviado porMohamedRefaatMohamed
- Documentopqs_e01_cr_fr01_vp1_2enviado porMohamedRefaatMohamed
- DocumentoWHO PQS Performance Specifications Cold Rooms and Freezersenviado porMohamedRefaatMohamed
- DocumentoWhopir Lncpp 13-14jun05enviado porMohamedRefaatMohamed
- DocumentoWHOPIR_Ajanta24-26May2007enviado porMohamedRefaatMohamed
- DocumentoWHO Terminologyenviado porMohamedRefaatMohamed
- DocumentoSmart Fan Filter Unitenviado porMohamedRefaatMohamed
- DocumentoCamfil Cleanroom Design Standards and Energy Optimizationenviado porMohamedRefaatMohamed
- DocumentoWHO ESCPP 2014enviado porMohamedRefaatMohamed
- DocumentoFekra - Pharma Third Editionenviado porMohamedRefaatMohamed
- DocumentoFekra - Pharma Second Edition Finalenviado porMohamedRefaatMohamed
- DocumentoFekra - Pharma First Editionenviado porMohamedRefaatMohamed
- DocumentoHumidity Effect on Pharmaceuticalsenviado porMohamedRefaatMohamed
- DocumentoWHO TRS 957enviado porMohamedRefaatMohamed
- DocumentoWHO PQPenviado porMohamedRefaatMohamed
- DocumentoWHO QA Terminologyenviado porMohamedRefaatMohamed
- DocumentoWHO QA Terminologyenviado porMohamedRefaatMohamed
- DocumentoFDA Trainings UCM274065enviado porMohamedRefaatMohamed